[
  {
    "ts": null,
    "headline": "Becton, Dickinson: Hold, Momentum Is Gaining, Just Need More Growth",
    "summary": "Financial writer rates Becton Dickinson and Co as a hold due to low growth and valuation concerns, despite positive indicators for future growth.",
    "url": "https://finnhub.io/api/news?id=6216cf63cc2a28c1b7f67eb0ee2e03e50fc0900e7a98d4d8a00406ce3b79c220",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737371405,
      "headline": "Becton, Dickinson: Hold, Momentum Is Gaining, Just Need More Growth",
      "id": 132430911,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1156479937/image_1156479937.jpg?io=getty-c-w1536",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "Financial writer rates Becton Dickinson and Co as a hold due to low growth and valuation concerns, despite positive indicators for future growth.",
      "url": "https://finnhub.io/api/news?id=6216cf63cc2a28c1b7f67eb0ee2e03e50fc0900e7a98d4d8a00406ce3b79c220"
    }
  },
  {
    "ts": null,
    "headline": "Intuitive Surgical: Second Half 2025 Guidance Is Critical To Maintaining Current Euphoria",
    "summary": "Intuitive Surgical's strong revenue growth and new product rollouts drive share price surge, but investors should be cautious of extreme valuation. Read my ISRG review.",
    "url": "https://finnhub.io/api/news?id=72d8759cc628c7f817121b487c15cda3b1ad8e4ed78b76ed943731927778771f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737360000,
      "headline": "Intuitive Surgical: Second Half 2025 Guidance Is Critical To Maintaining Current Euphoria",
      "id": 132430017,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1422720435/image_1422720435.jpg?io=getty-c-w1536",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "Intuitive Surgical's strong revenue growth and new product rollouts drive share price surge, but investors should be cautious of extreme valuation. Read my ISRG review.",
      "url": "https://finnhub.io/api/news?id=72d8759cc628c7f817121b487c15cda3b1ad8e4ed78b76ed943731927778771f"
    }
  },
  {
    "ts": null,
    "headline": "IYH: Healthcare Dashboard For January",
    "summary": "iShares U.S. Healthcare ETF has higher fees and lower performance. See why IYH is a top choice and learn about 10 cheaper healthcare stocks this January.",
    "url": "https://finnhub.io/api/news?id=86abfb300be5fe18fd5f0ffd4e4f143d62a99946668de83db5584543560aa5e1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737351767,
      "headline": "IYH: Healthcare Dashboard For January",
      "id": 132429429,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154850841/image_2154850841.jpg?io=getty-c-w1536",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "iShares U.S. Healthcare ETF has higher fees and lower performance. See why IYH is a top choice and learn about 10 cheaper healthcare stocks this January.",
      "url": "https://finnhub.io/api/news?id=86abfb300be5fe18fd5f0ffd4e4f143d62a99946668de83db5584543560aa5e1"
    }
  }
]